Skip to main content
Top
Published in: Inflammation 2/2014

01-04-2014

Neutrophil-to-Lymphocyte Ratio in Chronic Obstructive Pulmonary Disease: A Retrospective Study

Authors: Ersin Günay, Sevinç Sarınç Ulaşlı, Olcay Akar, Ahmet Ahsen, Sibel Günay, Tülay Koyuncu, Mehmet Ünlü

Published in: Inflammation | Issue 2/2014

Login to get access

Abstract

Chronic obstructive pulmonary disease (COPD) is a common chronic inflammatory disease of the lung with a high mortality and morbidity rate. Some of the inflammatory markers such as C-reactive protein (CRP), leukocyte count are associated with COPD. In this study, we aimed to evaluate the role of neutrophil-to-lymphocyte ratio (NLR) in COPD patients comparing with the other well-known inflammatory markers. We retrospectively enrolled the laboratory results of 269 COPD patients of which 178 patients at stable period and 91 patients during acute exacerbation and 50 sex- and age- matched healthy controls. We found that NLR values of the stable COPD patients were significantly higher than those of the controls (P < 0.001). During acute exacerbation of the disease there was a further increase compared to stable period (P < 0.001). NLR values were also positively correlated with serum CRP levels and red cell distribution width (RDW) and negatively correlated with mean platelet volume (MPV) in both COPD groups. In conclusion, NLR could be considered as a new inflammatory marker for assessment of inflammation in COPD patients with its quick, cheap, easily measurable property with routine complete blood count analysis.
Literature
1.
go back to reference MacNee, W. 2012. Chronic obstructive pulmonary disease: Epidemiology, pathophysiology, and clinical evaluation. In Clinical respiratory medicine, 4th ed, ed. S.G. Spiro, G.A. Silvestri, and A. Agusti, 531–561. Philadelphia: Elsevier Saunders.CrossRef MacNee, W. 2012. Chronic obstructive pulmonary disease: Epidemiology, pathophysiology, and clinical evaluation. In Clinical respiratory medicine, 4th ed, ed. S.G. Spiro, G.A. Silvestri, and A. Agusti, 531–561. Philadelphia: Elsevier Saunders.CrossRef
2.
go back to reference Hogg, J.C., F. Chu, S. Utokaparch, R. Woods, W.M. Elliott, L. Buzatu, et al. 2004. The nature of small airway obstruction in chronic obstructive pulmonary disease. New England Journal of Medicine 350: 2645–2653.PubMedCrossRef Hogg, J.C., F. Chu, S. Utokaparch, R. Woods, W.M. Elliott, L. Buzatu, et al. 2004. The nature of small airway obstruction in chronic obstructive pulmonary disease. New England Journal of Medicine 350: 2645–2653.PubMedCrossRef
3.
go back to reference Eagan, T.M., J.K. Damås, T. Ueland, M. Voll-Aanerud, T.E. Mollnes, J.A. Hardie, et al. 2010. Neutrophil gelatinase-associated lipocalin: A biomarker in COPD. Chest 138: 888–895.PubMedCrossRef Eagan, T.M., J.K. Damås, T. Ueland, M. Voll-Aanerud, T.E. Mollnes, J.A. Hardie, et al. 2010. Neutrophil gelatinase-associated lipocalin: A biomarker in COPD. Chest 138: 888–895.PubMedCrossRef
4.
go back to reference Agustí, A.G., A. Noguera, J. Sauleda, E. Sala, J. Pons, and X. Busquets. 2003. Systemic effects of chronic obstructive pulmonary disease. European Respiratory Journal 21: 347–360.PubMedCrossRef Agustí, A.G., A. Noguera, J. Sauleda, E. Sala, J. Pons, and X. Busquets. 2003. Systemic effects of chronic obstructive pulmonary disease. European Respiratory Journal 21: 347–360.PubMedCrossRef
5.
go back to reference Gan, W.Q., S.F. Man, A. Senthilselvan, and D.D. Sin. 2004. Association between chronic obstructive pulmonary disease and systemic inflammation: A systematic review and a meta-analysis. Thorax 59: 574–580.PubMedCentralPubMedCrossRef Gan, W.Q., S.F. Man, A. Senthilselvan, and D.D. Sin. 2004. Association between chronic obstructive pulmonary disease and systemic inflammation: A systematic review and a meta-analysis. Thorax 59: 574–580.PubMedCentralPubMedCrossRef
6.
go back to reference Thomsen, M., T.S. Ingebrigtsen, J.L. Marott, M. Dahl, P. Lange, J. Vestbo, et al. 2013. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease. JAMA 309: 2353–2361.PubMedCrossRef Thomsen, M., T.S. Ingebrigtsen, J.L. Marott, M. Dahl, P. Lange, J. Vestbo, et al. 2013. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease. JAMA 309: 2353–2361.PubMedCrossRef
7.
go back to reference Pinto-Plata, V.M., H. Müllerova, J.F. Toso, M. Feudjo-Tepie, J.B. Soriano, R.S. Vessey, et al. 2006. C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax 61: 23–28.PubMedCentralPubMedCrossRef Pinto-Plata, V.M., H. Müllerova, J.F. Toso, M. Feudjo-Tepie, J.B. Soriano, R.S. Vessey, et al. 2006. C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax 61: 23–28.PubMedCentralPubMedCrossRef
8.
go back to reference Antonescu-Turcu, A.L., and R. Tomic. 2009. C-reactive protein and copeptin: Prognostic predictors in chronic obstructive pulmonary disease exacerbations. Current Opinion in Pulmonary Medicine 15: 120–125.PubMedCrossRef Antonescu-Turcu, A.L., and R. Tomic. 2009. C-reactive protein and copeptin: Prognostic predictors in chronic obstructive pulmonary disease exacerbations. Current Opinion in Pulmonary Medicine 15: 120–125.PubMedCrossRef
9.
go back to reference Hotchkiss, R.S., and I.E. Karl. 2003. The pathophysiology and treatment of sepsis. New England Journal of Medicine 348: 138–150.PubMedCrossRef Hotchkiss, R.S., and I.E. Karl. 2003. The pathophysiology and treatment of sepsis. New England Journal of Medicine 348: 138–150.PubMedCrossRef
10.
go back to reference Ahsen, A., M.S. Ulu, S. Yuksel, K. Demir, M. Uysal, M. Erdogan, et al. 2013. As a new inflammatory marker for familial Mediterranean fever: Neutrophil-to-lymphocyte ratio. Inflammation [Epub ahead of print]. Ahsen, A., M.S. Ulu, S. Yuksel, K. Demir, M. Uysal, M. Erdogan, et al. 2013. As a new inflammatory marker for familial Mediterranean fever: Neutrophil-to-lymphocyte ratio. Inflammation [Epub ahead of print].
11.
go back to reference Núñez, J., E. Núñez, V. Bodí, J. Sanchis, G. Miñana, L. Mainar, et al. 2008. Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction. American Journal of Cardiology 101: 747–752.PubMedCrossRef Núñez, J., E. Núñez, V. Bodí, J. Sanchis, G. Miñana, L. Mainar, et al. 2008. Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction. American Journal of Cardiology 101: 747–752.PubMedCrossRef
12.
go back to reference Turkmen, K., F.M. Erdur, F. Ozcicek, A. Ozcicek, E.M. Akbas, A. Ozbicer, et al. 2013. Platelet-to-lymphocyte ratio better predicts inflammation than neutrophil-to-lymphocyte ratio in end-stage renal disease patients. Hemodialysis International 17: 391–396.PubMedCrossRef Turkmen, K., F.M. Erdur, F. Ozcicek, A. Ozcicek, E.M. Akbas, A. Ozbicer, et al. 2013. Platelet-to-lymphocyte ratio better predicts inflammation than neutrophil-to-lymphocyte ratio in end-stage renal disease patients. Hemodialysis International 17: 391–396.PubMedCrossRef
13.
go back to reference Ertaş, G., O. Sönmez, M. Turfan, S. Kul, E. Erdoğan, A. Tasal, et al. 2013. Neutrophil/lymphocyte ratio is associated with thromboembolic stroke in patients with non-valvular atrial fibrillation. Journal of the Neurological Sciences 324: 49–52.PubMedCrossRef Ertaş, G., O. Sönmez, M. Turfan, S. Kul, E. Erdoğan, A. Tasal, et al. 2013. Neutrophil/lymphocyte ratio is associated with thromboembolic stroke in patients with non-valvular atrial fibrillation. Journal of the Neurological Sciences 324: 49–52.PubMedCrossRef
14.
go back to reference Celli, B.R., W. MacNee, and ATS/ERS Task Force. 2004. Standards for the diagnosis and treatment of patients with COPD: A summary of the ATS/ERS position paper. European Respiratory Journal 23: 932–946.PubMedCrossRef Celli, B.R., W. MacNee, and ATS/ERS Task Force. 2004. Standards for the diagnosis and treatment of patients with COPD: A summary of the ATS/ERS position paper. European Respiratory Journal 23: 932–946.PubMedCrossRef
15.
go back to reference Anthonisen, N.R., J. Manfreda, C.P. Warren, E.S. Hershfield, G.K. Harding, and N.A. Nelson. 1987. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Annals of Internal Medicine 106: 196–204.PubMedCrossRef Anthonisen, N.R., J. Manfreda, C.P. Warren, E.S. Hershfield, G.K. Harding, and N.A. Nelson. 1987. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Annals of Internal Medicine 106: 196–204.PubMedCrossRef
16.
go back to reference Günay, E., S.S. Ulasli, E. Kacar, B. Halici, E. Unlu, K. Tünay, et al. 2013. Can platelet indices predict obstruction level of pulmonary vascular bed in patients with acute pulmonary embolism? Clinical Respiratory Journal [Epub ahead of print]. Günay, E., S.S. Ulasli, E. Kacar, B. Halici, E. Unlu, K. Tünay, et al. 2013. Can platelet indices predict obstruction level of pulmonary vascular bed in patients with acute pulmonary embolism? Clinical Respiratory Journal [Epub ahead of print].
18.
go back to reference Stockley, R.A. 2009. Progression of chronic obstructive pulmonary disease: Impact of inflammation, comorbidities and therapeutic intervention. Current Medical Research and Opinion 25: 1235–1245.PubMedCrossRef Stockley, R.A. 2009. Progression of chronic obstructive pulmonary disease: Impact of inflammation, comorbidities and therapeutic intervention. Current Medical Research and Opinion 25: 1235–1245.PubMedCrossRef
19.
go back to reference Schols, A.M., W.A. Buurman, A.J. Staal van den Brekel, M.A. Dentener, and E.F. Wouters. 1996. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax 51: 819–824.PubMedCentralPubMedCrossRef Schols, A.M., W.A. Buurman, A.J. Staal van den Brekel, M.A. Dentener, and E.F. Wouters. 1996. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax 51: 819–824.PubMedCentralPubMedCrossRef
20.
go back to reference Nural, S., E. Günay, B. Halici, S. Celik, and M. Ünlü. 2013. Inflammatory processes and effects of continuous positive airway pressure (CPAP) in overlap syndrome. Inflammation 36: 66–74.PubMedCrossRef Nural, S., E. Günay, B. Halici, S. Celik, and M. Ünlü. 2013. Inflammatory processes and effects of continuous positive airway pressure (CPAP) in overlap syndrome. Inflammation 36: 66–74.PubMedCrossRef
21.
go back to reference Donaldson, G.C., T.A. Seemungal, I.S. Patel, A. Bhowmik, T.M. Wilkinson, J.R. Hurst, et al. 2005. Airway and systemic inflammation and decline in lung function in patients with COPD. Chest 128: 1995–2004.PubMedCrossRef Donaldson, G.C., T.A. Seemungal, I.S. Patel, A. Bhowmik, T.M. Wilkinson, J.R. Hurst, et al. 2005. Airway and systemic inflammation and decline in lung function in patients with COPD. Chest 128: 1995–2004.PubMedCrossRef
22.
go back to reference Ulasli, S.S., B.A. Ozyurek, E.B. Yilmaz, and G. Ulubay. 2012. Mean platelet volume as an inflammatory marker in acute exacerbation of chronic obstructive pulmonary disease. Polskie Archiwum Medycyny Wewnętrznej 122: 284–290.PubMed Ulasli, S.S., B.A. Ozyurek, E.B. Yilmaz, and G. Ulubay. 2012. Mean platelet volume as an inflammatory marker in acute exacerbation of chronic obstructive pulmonary disease. Polskie Archiwum Medycyny Wewnętrznej 122: 284–290.PubMed
23.
go back to reference Wang, R.T., J.Y. Li, Z.G. Cao, and Y. Li. 2013. The Mean Platelet volume is decreased during an acute exacerbation of chronic obstructive pulmonary disease. Respirology [Epub ahead of print]. Wang, R.T., J.Y. Li, Z.G. Cao, and Y. Li. 2013. The Mean Platelet volume is decreased during an acute exacerbation of chronic obstructive pulmonary disease. Respirology [Epub ahead of print].
24.
go back to reference Steiropoulos, P., N. Papanas, E. Nena, M. Xanthoudaki, T. Goula, M. Froudarakis, et al. 2012. Mean platelet volume and platelet distribution width in patients with chronic obstructive pulmonary disease: The role of comorbidities. Angiology [Epub ahead of print]. Steiropoulos, P., N. Papanas, E. Nena, M. Xanthoudaki, T. Goula, M. Froudarakis, et al. 2012. Mean platelet volume and platelet distribution width in patients with chronic obstructive pulmonary disease: The role of comorbidities. Angiology [Epub ahead of print].
25.
go back to reference Güngör, B., K.S. Ozcan, I. Erdinler, A. Ekmekçi, A.T. Alper, D. Osmonov, et al. 2013. Elevated levels of RDW is associated with non-valvular atrial fibrillation. Journal of Thrombosis and Thrombolysis [Epub ahead of print]. Güngör, B., K.S. Ozcan, I. Erdinler, A. Ekmekçi, A.T. Alper, D. Osmonov, et al. 2013. Elevated levels of RDW is associated with non-valvular atrial fibrillation. Journal of Thrombosis and Thrombolysis [Epub ahead of print].
26.
go back to reference Ozsu, S., Y. Abul, S. Gunaydin, A. Orem, and T. Ozlu. 2012. Prognostic value of red cell distribution width in patients with pulmonary embolism. Clinical and Applied Thrombosis/Hemostasis [Epub ahead of print]. Ozsu, S., Y. Abul, S. Gunaydin, A. Orem, and T. Ozlu. 2012. Prognostic value of red cell distribution width in patients with pulmonary embolism. Clinical and Applied Thrombosis/Hemostasis [Epub ahead of print].
27.
go back to reference Ozsu, S., Y. Abul, A. Gulsoy, Y. Bulbul, S. Yaman, and T. Ozlu. 2012. Red cell distribution width in patients with obstructive sleep apnea syndrome. Lung 190: 319–326.PubMedCrossRef Ozsu, S., Y. Abul, A. Gulsoy, Y. Bulbul, S. Yaman, and T. Ozlu. 2012. Red cell distribution width in patients with obstructive sleep apnea syndrome. Lung 190: 319–326.PubMedCrossRef
28.
go back to reference Seyhan, E.C., M.A. Ozgül, N. Tutar, I. Omür, A. Uysal, and S. Altın. 2013. Red blood cell distribution and survival in patients with chronic obstructive pulmonary disease. COPD 10: 416–424.PubMedCrossRef Seyhan, E.C., M.A. Ozgül, N. Tutar, I. Omür, A. Uysal, and S. Altın. 2013. Red blood cell distribution and survival in patients with chronic obstructive pulmonary disease. COPD 10: 416–424.PubMedCrossRef
29.
go back to reference Sincer, I., A. Zorlu, M.B. Yilmaz, O.T. Dogan, M.R. Ege, G. Amioglu, et al. 2012. Relationship between red cell distribution width and right ventricular dysfunction in patients with chronic obstructive pulmonary disease. Heart and Lung 41: 238–243.PubMedCrossRef Sincer, I., A. Zorlu, M.B. Yilmaz, O.T. Dogan, M.R. Ege, G. Amioglu, et al. 2012. Relationship between red cell distribution width and right ventricular dysfunction in patients with chronic obstructive pulmonary disease. Heart and Lung 41: 238–243.PubMedCrossRef
30.
go back to reference Celikbilek, M., S. Dogan, O. Ozbakır, G. Zararsız, H. Kücük, S. Gürsoy, et al. 2013. Neutrophil–lymphocyte ratio as a predictor of disease severity in ulcerative colitis. Journal of Clinical Laboratory Analysis 27: 72–76.PubMedCrossRef Celikbilek, M., S. Dogan, O. Ozbakır, G. Zararsız, H. Kücük, S. Gürsoy, et al. 2013. Neutrophil–lymphocyte ratio as a predictor of disease severity in ulcerative colitis. Journal of Clinical Laboratory Analysis 27: 72–76.PubMedCrossRef
31.
go back to reference Okyay, G.U., S. Inal, K. Oneç, R.E. Er, O. Paşaoğlu, H. Paşaoğlu, et al. 2013. Neutrophil to lymphocyte ratio in evaluation of inflammation in patients with chronic kidney disease. Renal Failure 35: 29–36.PubMedCrossRef Okyay, G.U., S. Inal, K. Oneç, R.E. Er, O. Paşaoğlu, H. Paşaoğlu, et al. 2013. Neutrophil to lymphocyte ratio in evaluation of inflammation in patients with chronic kidney disease. Renal Failure 35: 29–36.PubMedCrossRef
Metadata
Title
Neutrophil-to-Lymphocyte Ratio in Chronic Obstructive Pulmonary Disease: A Retrospective Study
Authors
Ersin Günay
Sevinç Sarınç Ulaşlı
Olcay Akar
Ahmet Ahsen
Sibel Günay
Tülay Koyuncu
Mehmet Ünlü
Publication date
01-04-2014
Publisher
Springer US
Published in
Inflammation / Issue 2/2014
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-013-9749-1

Other articles of this Issue 2/2014

Inflammation 2/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.